Medtronic (MDT)
83.89
0.99 (1.19%)
At close: Apr 14, 2025, 3:13 PM
1.19% (1D)
| Bid | 83.86 |
| Market Cap | 107.59B |
| Revenue (ttm) | 33.2B |
| Net Income (ttm) | 4.26B |
| EPS (ttm) | 3.28 |
| PE Ratio (ttm) | 25.58 |
| Forward PE | 15.79 |
| Analyst | Hold |
| Ask | 83.93 |
| Volume | 3,267,149 |
| Avg. Volume (20D) | 8,647,817.9 |
| Open | 83.97 |
| Previous Close | 82.90 |
| Day's Range | 83.25 - 84.03 |
| 52-Week Range | 75.96 - 96.25 |
| Beta | 0.81 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides ...
Industry Medical - Devices
Sector Healthcare
IPO Date May 2, 1973
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Website https://www.medtronic.com
Analyst Forecast
According to 14 analyst ratings, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $95, which is an increase of 13.24% from the latest price.
Stock ForecastsNext Earnings Release
Medtronic is scheduled to release its earnings on May 22, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-7.26%
Medtronic shares are trading lower after the compa...
Unlock content with
Pro Subscription
2 months ago
+4.23%
Medtronic shares are trading higher after the company announced that the Centers for Medicare & Medicaid Services is opening a national coverage analysis for Symplicity Spyral Renal Denervation System.
